The FDA Releases a New Webpage During Covid-19 Outbreak

The U.S. Food and Drug Administration (FDA) released a new webpage of information to help address questions patients and caregivers may have about FDA-regulated medical products (drugs, biologics, and devices) during the coronavirus (COVID-19) outbreak. The webpage is a source of information for patients during this time of crisis. Visitors to the page can find information on:

  • FDA COVID-19 resources, such as questions and answers on hand sanitizers;
  • How patients can report a drug, biologic, or medical device product shortage; and
  • Information on clinical trials and the FDA’s Expanded Access program.


Please visit the webpage at For additional questions you may have, please contact the FDA’s Patient Affairs Staff at 301-796-8460 or email

Other Patient Resources:

For Patients


Questions and Answers for Patients About Clinical Trials During COVID-19 Outbreak


Patient Affairs Staff (PAS)
Office of the Commissioner
U.S. Food and Drug Administration

Tel: 301-796-8460


Want to learn more about how PAS works to improve, expand and maintain communication with patients, check out the Patient Affairs Staff webpage, email us at or follow us on Twitter @FDAPatientInfo.

Should you wish to opt-out of future communications from the Patient Affairs Staff, please send an email to




Back to all News